Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing.

Nie C., Yang D., Morris SF.

Laboratory Study on Chronic Wound, published in Med Hypotheses (2009) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Med Hypotheses (2009)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
19243892
DOI
10.1016/j.mehy.2008.10.033
Citations
62

Abstract (original English)

Wounds, characterized by leading to a loss of integrity of the skin and a major cause of morbidity and mortality, are common challenges encountered in plastic and reconstructive surgery. The primary goals of treatment are rapid closure, restoration of function, and aesthetical satisfaction. Adult stem cells may provide new strategies to treat cutaneous wounds because of their prolonged self-renewal capacity and ability to differentiate into various tissues. In the past five years, some researches discovered bone marrow mesenchymal cells (BMSCs) could accelerate wound healing. However, there exist several disadvantages of BMSCs mainly including the limitation of the obtainable amount and the impairment of their differentiation abilities with the increasing age. Due to the limitation of BMSCs in clinical application, we turn to consider adipose-derived stem cells (ASCs) as seeding cells in tissue repair for their own advantages. ASCs could not only possess capacity to differentiate into various lineages under appropriate conditions, but also release angiogenic factors that stimulate angiogenesis in ischemia injury models. Here we propose the hypothesis that ASCs locally delivered via acellular dermal matrix as a scaffold would enhance wound healing through both differentiation into endothelial and epithelial cells and production of angiogenic growth factors in cutaneous wounds. F

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesCell-Free SystemDermatologic Surgical ProceduresExtracellular MatrixHumansSkinStem Cell TransplantationWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research